Impax Asset Management Group PLC Travere Therapeutics, Inc. Transaction History
Impax Asset Management Group PLC
- $19.8 Billion
- Q4 2024
A detailed history of Impax Asset Management Group PLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 300,000 shares of TVTX stock, worth $6.36 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$6.36 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
199Shares Held
85MCall Options Held
776KPut Options Held
912K-
Armistice Capital, LLC New York, NY7.65MShares$162 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$162 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$146 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$99.4 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$92.1 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.36B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...